1. Home
  2. BIO vs KNX Comparison

BIO vs KNX Comparison

Compare BIO & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • KNX
  • Stock Information
  • Founded
  • BIO 1952
  • KNX 1989
  • Country
  • BIO United States
  • KNX United States
  • Employees
  • BIO N/A
  • KNX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • KNX Trucking Freight/Courier Services
  • Sector
  • BIO Industrials
  • KNX Industrials
  • Exchange
  • BIO Nasdaq
  • KNX Nasdaq
  • Market Cap
  • BIO 7.7B
  • KNX 6.4B
  • IPO Year
  • BIO N/A
  • KNX 1994
  • Fundamental
  • Price
  • BIO $341.54
  • KNX $45.58
  • Analyst Decision
  • BIO Strong Buy
  • KNX Strong Buy
  • Analyst Count
  • BIO 4
  • KNX 17
  • Target Price
  • BIO $333.50
  • KNX $53.65
  • AVG Volume (30 Days)
  • BIO 217.1K
  • KNX 4.9M
  • Earning Date
  • BIO 10-29-2025
  • KNX 10-22-2025
  • Dividend Yield
  • BIO N/A
  • KNX 1.59%
  • EPS Growth
  • BIO N/A
  • KNX 280.63
  • EPS
  • BIO 11.49
  • KNX 0.88
  • Revenue
  • BIO $2,554,200,000.00
  • KNX $7,477,640,000.00
  • Revenue This Year
  • BIO $2.05
  • KNX $2.21
  • Revenue Next Year
  • BIO $2.86
  • KNX $5.78
  • P/E Ratio
  • BIO $29.57
  • KNX $51.65
  • Revenue Growth
  • BIO N/A
  • KNX N/A
  • 52 Week Low
  • BIO $211.43
  • KNX $36.69
  • 52 Week High
  • BIO $387.99
  • KNX $61.51
  • Technical
  • Relative Strength Index (RSI)
  • BIO 74.58
  • KNX 55.41
  • Support Level
  • BIO $326.64
  • KNX $43.77
  • Resistance Level
  • BIO $322.29
  • KNX $48.38
  • Average True Range (ATR)
  • BIO 10.29
  • KNX 1.79
  • MACD
  • BIO 3.75
  • KNX 0.20
  • Stochastic Oscillator
  • BIO 98.74
  • KNX 56.17

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: